This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]
A letter from departing BIO president Jim Greenwood originally sent May 27, 2020 After more than fifteen years as President and CEO of BIO, I will pass the baton to Michelle McMurry-Heath on June 1st. It has been a fascinating period for me and for the biotechnology sector. I am proud of the unparalleled team […]
Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY – May 27, 2020 – (Alucent Biomedical) Alucent Biomedical Inc. announced that it has enrolled the first two patients in ACTIVATE I, a Phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding […]
Park City, Utah USA, May 12, 2020 /PRNewswire/ — Transit Scientific announced the FDA cleared the XO Cross Microcatheter platform for guidewire support, exchange, and contrast media injection in the peripheral vasculature. Microcatheters are small 0.70-1.30mm outer diameter (OD) catheters used to provide guidewire support, facilitate guidewire exchanges, access distal anatomy, cross lesions, deliver therapeutic […]
How can we advance the utilization of innovations in healthcare? By lending them extra visibility to key stakeholders! Join the Impactful Innovation Exchange, a free comprehensive platform that will showcase solutions from various organizations, created by Cambia Grove, with supporting organizations including BioUtah. Learn more and submit yours for FREE today: https://bit.ly/CGInnovationSubmission […]
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner of the State of Utah for many years. As a German investment promotion agency, we can observe the economic trends developing in our crisis-stricken global economy first-hand. We are honored that BioUtah has asked us to provide […]
PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]
PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]
SALT LAKE CITY, April 14, 2020 /PRNewswire/ — Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope for minimally invasive abdominal and thoracic surgery. The Xenoscope 5mm articulating disposable laparoscope is designed to improve image quality, reduce fog, lower hospital costs, and reduce bio-hazard risk for the patient and staff. Read the article below on […]
WASHINGTON—U.S. Senator Mitt Romney (R-UT) today announced the launch of a new webpage designed to keep Utahns informed during the coronavirus pandemic. The webpage, which serves as a reference guide for information from federal agencies, as well as state and local authorities, includes guidance for seniors and at-risk individuals, veterans, families and small businesses. The […]
Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]
FOR IMMEDIATE RELEASE: March 20, 2020 Media Contact: Ally Riding (202) 226-7721 Washington, DC— Today, Representative John Curtis (R-UT) sent a letter to United States Department of the Treasury Secretary Steven Mnuchin asking for relief for small businesses who are obligated to make paid leave payments to employees under the newly signed Families First […]